(Q37631055)

21 August 2017

1 reference

title

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? (English)

1 reference

21 August 2017

1 reference

3

Kadaba S Sriprakash

1 reference

21 August 2017

4

Melina M Georgousakis

0 references

author name string

Pierre R Smeesters

series ordinal

1

1 reference

21 August 2017

David J McMillan

series ordinal

2

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

1705-1720

1 reference

The global burden of group A streptococcal diseases

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Burden and economic cost of group A streptococcal pharyngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Group A streptococci in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Rise and persistence of global M1T1 clone of Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Pathogenesis of group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Rheumatic heart disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

The high burden of rheumatic heart disease found on autopsy in Fiji

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Rheumatic fever in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Molecular basis of group A streptococcal virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Lateral genetic transfers between group A and G streptococci for M-like genes are ongoing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Group A streptococci efficiently invade human respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Pathogenesis of group A streptococcal infections and their sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Rheumatic fever following streptococcal vaccination. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Acute rheumatic fever: a chink in the chain that links the heart to the throat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Evolutionary Origin and Emergence of a Highly Successful Clone of Serotype M1 Group A Streptococcus Involved Multiple Horizontal Gene Transfer Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Epidemiology of severe Streptococcus pyogenes disease in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Protective Studies with Group A Streptococcal M Protein Vaccine. III. Challenge of Volunteers after Systemic or Intranasal Immunization with Type 3 or Type 12 Group A Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Myosin: a link between streptococci and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Immunogenicity of a 26-valent group A streptococcal vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Active bacterial core surveillance of the emerging infections program network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Characterisation of group A streptococcal isolates from tropical Australia with high prevalence of rheumatic fever: probing for signature sequences to identify members of the family of serotype 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Increase in group G streptococcal infections in a community hospital, New York, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

The role of group C and group G streptococci in acute pharyngitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Survey of emm-like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Towards a vaccine against rheumatic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Use of 16S rRNA gene terminal restriction fragment analysis to assess the impact of solids retention time on the bacterial diversity of activated sludge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999: overlap with type distribution within the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

High diversity of group A streptococcal emm types among healthy schoolchildren in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Molecular heterogeneity among north Indian isolates of Group A Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Epidemiological analysis of group A streptococci recovered from patients in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Genetic analysis of group A streptococcus isolates recovered during acute glomerulonephritis outbreaks in Guizhou Province of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Antibiotic resistance and genotypic characteristics of group a streptococci associated with acute pharyngitis in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Distribution of T types and emm Genotypes of Streptococcus pyogenes in Jinju, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Distribution of emm genotypes among group A streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Skin infections among Indigenous Australians in an urban setting in far North Queensland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Strain Prevalence, Rather than Innate Virulence Potential, Is the Major Factor Responsible for an Increase in Serious Group A Streptococcus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Inter-species genetic movement may blur the epidemiology of streptococcal diseases in endemic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Protective Immune Response againstStreptococcus pyogenesin Mice after Intranasal Vaccination with the Fibronectin‐Binding Protein SfbI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

Intracellular Penetration and Survival ofStreptococcus pyogenesin Respiratory Epithelial CellsIn Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.133

21 January 2018

Identifiers

DOI

10.1586/ERV.09.133

1 reference

21 August 2017

1 reference